183 related articles for article (PubMed ID: 27171002)
1. MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
Egaña-Gorroño L; Guardo AC; Bargalló ME; Planet E; Vilaplana E; Escribà T; Pérez I; Gatell JM; García F; Arnedo M; Plana M M;
PLoS One; 2016; 11(5):e0155245. PubMed ID: 27171002
[TBL] [Abstract][Full Text] [Related]
2. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.
Egaña-Gorroño L; Escribà T; Boulanger N; Guardo AC; León A; Bargalló ME; Garcia F; Gatell JM; Plana M; Arnedo M;
PLoS One; 2014; 9(9):e106360. PubMed ID: 25225963
[TBL] [Abstract][Full Text] [Related]
3. Utility of Systematic Isolation of immune cell subsets from HIV-infected individuals for miRNA profiling.
Bargalló ME; Guardo AC; Maleno MJ; Miralles L; Egaña-Gorroño L; Escribà T; García F; Gatell JM; Arnedo M; Plana M
J Immunol Methods; 2017 Mar; 442():12-19. PubMed ID: 28039100
[TBL] [Abstract][Full Text] [Related]
4. Elevated Expression of miR-19b Enhances CD8
Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
Front Immunol; 2018; 9():3140. PubMed ID: 30687333
[TBL] [Abstract][Full Text] [Related]
5. T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.
Downey JS; Attaf M; Moyle G; Gazzard B; Gotch F; Imami N
AIDS; 2011 Oct; 25(16):1981-6. PubMed ID: 21811141
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.
Duskova K; Nagilla P; Le HS; Iyer P; Thalamuthu A; Martinson J; Bar-Joseph Z; Buchanan W; Rinaldo C; Ayyavoo V
BMC Infect Dis; 2013 May; 13():250. PubMed ID: 23721325
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-210, MicroRNA-331, and MicroRNA-7 Are Differentially Regulated in Treated HIV-1-Infected Individuals and Are Associated With Markers of Systemic Inflammation.
Ballegaard V; Ralfkiaer U; Pedersen KK; Hove M; Koplev S; Brændstrup P; Ryder LP; Madsen HO; Gerstoft J; Grønbæk K; Nielsen SD
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):e104-e113. PubMed ID: 27749601
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional insights into the CD8
Li SY; Zhang ZN; Jiang YJ; Fu YJ; Shang H
J Transl Med; 2020 Feb; 18(1):96. PubMed ID: 32093694
[TBL] [Abstract][Full Text] [Related]
9. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.
Witwer KW; Watson AK; Blankson JN; Clements JE
Retrovirology; 2012 Jan; 9():5. PubMed ID: 22240256
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of miR-155 is associated with the differentiation of CD8+ T cells in patients with HIV-1.
Jin C; Cheng L; Lu X; Xie T; Wu H; Wu N
Mol Med Rep; 2017 Aug; 16(2):1584-1589. PubMed ID: 28627655
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic meta-analysis identifies gene expression characteristics in various samples of HIV-infected patients with nonprogressive disease.
Zhang LL; Zhang ZN; Wu X; Jiang YJ; Fu YJ; Shang H
J Transl Med; 2017 Sep; 15(1):191. PubMed ID: 28899396
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
13. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
[TBL] [Abstract][Full Text] [Related]
14. Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression.
Hubert A; Subra C; Jenabian MA; Tremblay Labrecque PF; Tremblay C; Laffont B; Provost P; Routy JP; Gilbert C
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):219-27. PubMed ID: 26181817
[TBL] [Abstract][Full Text] [Related]
15. Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.
López M; Soriano V; Peris-Pertusa A; Rallón N; Restrepo C; Benito JM
AIDS Res Hum Retroviruses; 2011 Feb; 27(2):157-65. PubMed ID: 20964478
[TBL] [Abstract][Full Text] [Related]
16. Metabolic pathway activation distinguishes transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.
Chowdhury FZ; Ouyang Z; Buzon M; Walker BD; Lichterfeld M; Yu XG
AIDS; 2018 Nov; 32(18):2669-2677. PubMed ID: 30289807
[TBL] [Abstract][Full Text] [Related]
17. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ
BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598
[TBL] [Abstract][Full Text] [Related]
18. Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells.
Jensen SS; Fomsgaard A; Larsen TK; Tingstedt JL; Gerstoft J; Kronborg G; Pedersen C; Karlsson I
PLoS One; 2015; 10(10):e0139573. PubMed ID: 26426913
[TBL] [Abstract][Full Text] [Related]
19. The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.
Ndhlovu ZM; Stampouloglou E; Cesa K; Mavrothalassitis O; Alvino DM; Li JZ; Wilton S; Karel D; Piechocka-Trocha A; Chen H; Pereyra F; Walker BD
J Virol; 2015 Nov; 89(21):10735-47. PubMed ID: 26269189
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals.
Ndumbi P; Gilbert L; Tsoukas CM
PLoS One; 2015; 10(2):e0117039. PubMed ID: 25647167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
